OBJECTIVE: To describe the current status of breast, colorectal and cervical cancer screening in Spain. METHODOLOGY: The situation was analysed on the basis of data drawn from surveys conducted in each autonomous region (Comunidad Autónoma). RESULTS: Currently, breast cancer screening coverage is 100%. In 2007, overall participation was 67.0% with an adherence of 91.2%. The detection rate was 3.4 per thousand, 15.1% intraductal and 30% invasive <1 cm in diameter, with 65% showing axilary node negative. Colorectal cancer screening had been implemented in six regions (4.5% of the target population). Participation ranged from 17.2% to 42.3%, with positive test percentages ranging from 1.7 per thousand (guaiac) to 9.5% (immunological). The invasive cancer detection rate was 1.7 per thousand (guaiac) and 3.4 per thousand (immunological). In most cases, cervical cancer screening was undertaken opportunistically, with an estimated coverage of 69.0%. CONCLUSIONS: In Spain, cancer screening is being conducted in accordance with national and international recommendations. The fact that screening programmes are operated as a network has led to a high degree of consensus as to the methodology and information systems to be used to enable joint evaluation.
OBJECTIVE: To describe the current status of breast, colorectal and cervical cancer screening in Spain. METHODOLOGY: The situation was analysed on the basis of data drawn from surveys conducted in each autonomous region (Comunidad Autónoma). RESULTS: Currently, breast cancer screening coverage is 100%. In 2007, overall participation was 67.0% with an adherence of 91.2%. The detection rate was 3.4 per thousand, 15.1% intraductal and 30% invasive <1 cm in diameter, with 65% showing axilary node negative. Colorectal cancer screening had been implemented in six regions (4.5% of the target population). Participation ranged from 17.2% to 42.3%, with positive test percentages ranging from 1.7 per thousand (guaiac) to 9.5% (immunological). The invasive cancer detection rate was 1.7 per thousand (guaiac) and 3.4 per thousand (immunological). In most cases, cervical cancer screening was undertaken opportunistically, with an estimated coverage of 69.0%. CONCLUSIONS: In Spain, cancer screening is being conducted in accordance with national and international recommendations. The fact that screening programmes are operated as a network has led to a high degree of consensus as to the methodology and information systems to be used to enable joint evaluation.
Authors: D Major; D Armstrong; H Bryant; W Cheung; K Decker; G Doyle; V Mai; C M McLachlin; J Niu; J Payne; N Shukla Journal: Curr Oncol Date: 2015-08 Impact factor: 3.677
Authors: J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet Journal: Clin Transl Oncol Date: 2017-01-16 Impact factor: 3.405
Authors: Marilina García; Maximino Redondo; Irene Zarcos; Javier Louro; Francisco Rivas-Ruiz; Teresa Téllez; Diego Pérez; Francisco Medina Cano; Kenza Machan; Laia Domingo; Maria Del Mar Vernet; Maria Padilla-Ruiz; Xavier Castells; Maria Sala Journal: Eur J Breast Health Date: 2022-04-01
Authors: M T Martínez; I González; N Tarazona; S Roselló; R Saiz; A Sanmartín; Á Martínez-Agulló; A Caballero; P Mas; J Franco; J Martínez-Jabaloyas; J García-Callejo; V Martín; J Navarro; A Teruel; A Lluch; I Chirivella Journal: Clin Transl Oncol Date: 2014-08-07 Impact factor: 3.405
Authors: Marina Pollán; Rafael Llobet; Josefa Miranda-García; Joaquín Antón; María Casals; Inmaculada Martínez; Carmen Palop; Francisco Ruiz-Perales; Carmen Sánchez-Contador; Carmen Vidal; Beatriz Pérez-Gómez; Dolores Salas-Trejo Journal: Springerplus Date: 2013-05-24
Authors: Roberto Pastor-Barriuso; Nieves Ascunce; María Ederra; Nieves Erdozáin; Alberto Murillo; José E Alés-Martínez; Marina Pollán Journal: Breast Cancer Res Treat Date: 2013-02-03 Impact factor: 4.872
Authors: Marina Pollán; Nieves Ascunce; María Ederra; Alberto Murillo; Nieves Erdozáin; Jose Alés-Martínez; Roberto Pastor-Barriuso Journal: Breast Cancer Res Date: 2013-01-29 Impact factor: 6.466